Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

Tech Hubs at RESI and Beyond

3 Feb

By Alexander Vassallo, Manager of Business Development West Coast (US), LSN

Life Science Nation (LSN)’s global network, built over the past decade, incorporates a host of exciting early-stage life science strategic partners, including Technology (Tech) Hubs. Due to the key role that Tech Hubs play in the early-stage life science arena, LSN has developed several Tech Hub-specific offerings to the central benefit of their constituents.

The first offering relates to a special 50% discount on standard 3-day registrations to any 2022 Redefining Early Stage Investments (RESI) partnering event – the nucleus of LSN’s global network partnerships. Provided the constituent has raised under $2M USD, they can attend RESI for $598, as opposed to the standard price of $1195. Constituents can partner with any number of the hundreds of active investors who attend RESI regularly, showcase their technology, and highlight why their company should be an investor’s top choice for 2022. For less than $600, this offer is rare in the life science partnering community, making it a no-brainer for cash-strapped businesses.

The second offer includes access to the LSN Investor Database. The LSN Investor Database helps startups raising their Seed to Series B funding rounds connect with active investors who are a right fit for their product and stage of development. The LSN Investor Database currently contains more than 10,000 global investors from over 2,500 investment firms across domains of therapeutics, medical devices, diagnostics, and digital health. When three, or more, tech hub constituents join, each constituent receives a four-month subscription, one free ticket to any 2022 RESI event, and a guaranteed slot in the Innovator’s Pitch Challenge (IPC) for $2,000 per startup. Individually, these components would cost $3,800, but through this Tech Hub Group Fundraising Package, constituents have even more to benefit from.

Finally, all Tech Hub partners that send at least one constituent to RESI in 2022 will receive a dedicated webpage for that respective conference. Tech Hubs can showcase all their organization has to offer by submitting materials to LSN including an organization description, introductory video, brochure, case studies, and more. LSN curates these materials into a dedicated webpage which grants an unparalleled opportunity for exposure with our network. This dedicated webpage is part of the Tech Hub Partnership Agreement, a free-of-cost arrangement between LSN and the Tech Hub that ensures maximum benefit for both parties.

Past RESI Tech Hubs

Tech Hub administrators and constituents alike can benefit from these special offers. If you’re interested in learning more, contact us, and our dedicated business development team is ready to see how we can be a meaningful stop along the way to fundraising success.

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International East Coast (USA) & China Midwest (USA)
& Canada
West Coast  (USA)
Alex
Greg Mannix
Vice President International Business Development, General Manager Europe
Book a Meeting
Email Me
Candice He
Vice President of Business Development, Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Alexander Vassallo
Manager of Business Development
Book a Meeting
Email Me

resi-march-2022

Panels at Digital RESI March

3 Feb

By Karen Deyo, Director of Investor Research, Israel BD, LSN

The Redefining Early Stage Investment (RESI) conference series is, first and foremost, a partnering event. However, in addition to being partnering-centric, RESI is also designed to provide unfettered access to “the room where it happens” in the form of investor panels designed to provide valuable insight into what investors want in 2022.

Digital RESI March will feature 13 panels, with 10 panels featuring investors sharing their insights and giving tips to fundraising companies, as well as 3 panels featuring startups sharing their successful fundraising stories, how they achieved it, and what they’ve learned along the way. The investor panels range in focus from Seed Funds to Medtech Strategics, and focusing on different sectors, from Mental & Behavioral Health to Cell & Gene Therapy. Additionally, there will be AI and Longevity-focused panels, two areas of the life sciences with increasing focus.

RESI is first and foremost a partnering conference, but this content offers many startups keen strategies to help them avoid common pitfalls when approaching investors. Attendees can take the time to watch the sessions live and ask the panelists questions, or choose to watch the panels at a later date, with the panel recordings available on the Live Agenda up to three weeks after the conference ends.

If your New Year’s resolution was to kick off an early-stage fundraise, you’re not alone, but RESI provides the actionable steps to get from point (or series) A to B. Check out our panels below and register by February 18 to save $200!

Digital RESI March 2022 Panels
Tuesday
March 22
11 AM EST Early-Stage Therapeutics
Bringing the Newest Therapies to the Clinic
2 PM EST Digital Health & Wellness
Silver-Tech Focusing on Preventative Car
3 PM EST Seed Funds
Investing in the Earliest Stage Companies
4 PM EST Tales from the Road: AI Innovators on their Fundraising Journey
Wednesday
March 23
11 AM EST Age-Tech Devices
Seniors Embrace Innovative Medtech for Better Quality of Life
2 PM EST Medtech Strategics
Large Corporations Seeking External Innovation in MedTech
3 PM EST AI Drug Discovery and Development
How AI is Accelerating Therapeutic Advancement
4 PM EST Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey
Thursday
March 24
11 AM EST Precision Medicine
Improving Outcomes through a Patient-Tailored Approach
1 PM EST Cell & Gene Therapy
The Next Generation of Therapeutic Technologies
2 PM EST Defining AI Investment
AI-Exclusive Investors Share Their Perspectives
4 PM EST Tales from the Road: Age-Tech Innovators on their Fundraising Journey

resi-march-2022

Super Early Bird Ends Tomorrow – Accelerate Your Fundraising Efforts at Digital RESI March 2022

27 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireWe just wrapped another successful Redefining Early Stage Investments (RESI) Conference, and now we are busily preparing for our next event: Digital RESI March 22-24.

Digital RESI March will bring together over 300 investor attendees who are interested in meeting startup companies for potential investment, strategic partnership, and more. In addition to all day partnering across the three-day conference, Digital RESI will feature an engaging program of investor panels, workshops, and Innovator’s Pitch Challenge (IPC) sessions. Super Early Bird rates are ending tomorrow, Friday, January 28th. Don’t miss out on the opportunity to save $300 on your registration!

resi-march-2022

Sponsorship at RESI: Getting your message to your target audience

27 Jan

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

As we enter year three of the Covid-19 pandemic, companies and organizations need to be creative about ways to get their message out and gain visibility. The days of attending networking events and making contacts in unplanned meetings are still on the horizon. In the absence of these ad hoc meetings, how do you reach your target audience?  How do you showcase your expertise to potential customers in the digital/virtual world we live in today?

Organizations that want to reach early-stage, life science startups can get great visibility at the Digital RESI March conference. Sponsors at RESI March have a myriad of opportunities to reach their target audience, such as hosting a live workshop at the event. At our last RESI conference, Digital RESI JPM, sponsors held live workshops on topics that really matter to start-ups, such as

  • Negotiating Term Sheets
  • Licensing in the Life Sciences
  • Evaluating your Banking Partner
  • Fundraising Challenges for First-time Entrepreneurs

Sessions like these put a spotlight on the expertise that sponsors have in certain areas and offer the chance to make connections with companies needing these services. In addition, the Service Provider Showcase on the RESI Live Agenda is great for brand recognition.

Let us know if you would like to discuss sponsorship opportunities at RESI. Contact Us!

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International East Coast (USA) & China Midwest (USA)
& Canada
West Coast  (USA)
Alex
Greg Mannix
Vice President International Business Development, General Manager Europe
Book a Meeting
Candice He
Vice President of Business Development, Global Investment Strategist
Book a Meeting
Antoinette Lowre
Manager of Business Development
Book a Meeting
Alexander Vassallo
Manager of Business Development
Book a Meeting

resi-march-2022

Pre-RESI Bootcamps – Preparing for the Innovator’s Pitch Challenge

27 Jan

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

At our recent RESI JPM conference, 55 selected life science startups pitched in 11 live Q&A sessions to relevant investor judges, in the Innovator’s Pitch Challenge. The IPC continues to be the most popular feature of the RESI conferences. Presenters benefited from showcasing their technology to both the investors on the judging panel and the audience. Additionally, many investor attendees said the unique format of IPC is an efficient way to learn about a company.

As the IPC is getting more traction, the Life Science Nation team will be hosting two FREE Pre-RESI Bootcamps on Preparing for the Innovator’s Pitch Challenge. The bootcamp will explain the timeline, format, and frequently asked questions from the investor panel, to help the interested companies to get a better understanding of what to expect and how to prepare to pitch at RESI.

Pre-RESI Bootcamps: Preparing for the Innovator’s Pitch Challenge
1 Wednesday, February 2nd at 12PM EST Register Here
2 Wednesday, February 23rd at 2PM EST Register Here

The pitch slots are limited, and we accept applications on a first-come, first-served basis, so we encourage you to fill out the free 5-min application at your earliest convenience.

apply-ipc

*A one-day or three-day registration + $800 pitch fee are required to participate.

resi-march-2022

Digital RESI JPM Winners

20 Jan

By Megan Rychwa, Investor Research Analyst, LSN

Last week, Life Science Nation wrapped up its second Digital RESI JPM and the first Innovators Pitch Challenge (IPC) of the year. As we prepare for Digital RESI March, we wanted to take this opportunity to announce and celebrate the winners of Digital RESI JPM IPC!

Learn more about the winners below and how their technology is making a difference in the early-stage life science ecosystem. The winners are picked by the votes cast from RESI attendees with exclusive access to the live IPC session and dedicated company landing pages and pitch materials.

The IPC returns March 22-24. Eligible startups can apply until Friday, February 25. All qualifying finalists must purchase a Digital RESI March registration and pay a $800 pitch fee. We accept applications on a rolling basis, so get yours in today!

apply-ipc

First Place – Amplified Sciences
Amplified Sciences is a startup life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases, including lethal cancers and organ loss with R&D operations in Purdue Research Park and research alliances in San Francisco and Boston. The company is developing a portfolio of diagnostic assays for early detection of disease. An ultra-sensitive molecular sensing technology licensed from Purdue operates with novel test-strips that combine with portable instrumentation to form a highly versatile clinical assay platform that can scale to point of care. The lead assay in development is at clinical testing stage and targets early detection of undiagnosed pancreatic cancers. The company closed a Seed round in 2020 which will enable technical and clinical validation of the PanCystPro product and position the company for entry into a commercializable lab-developed test in 2023.

Second Place – OncoXome
OncoXome is an oncology startup whose objective is to bring to patients with advanced cancer an innovative multitarget therapeutic approach hacking cell communication and using gene editing to overcome cancer resistance. They have two platforms: proprietary exosome scalable production and gene editing therapy. Combined, these platforms lead to targeted therapeutic delivery. They first target patients with advanced KRAS mutated lung, colorectal and pancreatic cancers.

Third Place – Prolifagen
Prolifagen is a Start Up company located in Philadelphia and working on a local injectable medicine based on microRNA to regenerate heart muscle damaged by MI and prevent heart failure.  [Approximately 400,000 people develop HF following massive MI yearly in US/EU combined, at a huge cost to society.] They have shown regeneration of cardiac muscle in mice and have early data of regeneration in pigs.  The next milestone will be to define the extent of clinical benefit in a pig model of myocardial infarct, as a steppingstone to clinical trials. They have issued patents in US/EU. So far, their funding has been based on non-dilutive funding from founders and on a phase 1 SBIR grant. They are looking for strategic investment and/or collaboration/licensing.

resi-march-2022

Digital RESI March Agenda

20 Jan

By Rory McCann, Marketing Manager & Conference Producer, LSN

It’s no secret that January is a time for action – new resolutions, new fundraising campaigns, and, of course, the annual J.P. Morgan Healthcare week – the Olympic torch of life science deal flow. At Life Science Nation, we know that fundraising is a numbers game, and just because January is winding down, doesn’t mean the early-stage ecosystem is. This is why the Redefining Early Stage Investments (RESI) conference series picks up where we left off March 22-24 with a whole new lineup of panels, workshops, pitch sessions, partnering, and more!

Check out our preliminary agenda and visit our website to learn more and see how you can get involved in Digital RESI March! Innovator’s Pitch Challenge applications are open until Friday, February 25, and panel recruitment is ongoing, so if you’re a fit for a panel topic, or if your company is ready to get in front of the right investors for your product and stage of development, contact us to learn more!

Digital RESI March 22-24, 2022 Agenda
Tuesday Wednesday Thursday
10AM EST IPC Session #1 Mental & Behavioral Health Panel IPC Session #8
IPC Session #5
11aM EST Early Stage Therapeutics Panel Age-Tech Devices Panel Precision Medicine Panel
12PM EST First Republic Bank
Workshop
MWE
Workshop
Burns & Levinson
Workshop
1PM EST IPC Session #2 IPC Session #6 Cell & Gene Therapy Panel
IPC Session #9
2PM EST Longevity, Health & Wellness Panel Medtech Strategics Panel Defining AI Investment Panel
3PM EST Seed Funds Panel AI Drug Discovery & Development Panel IPC Session #10
IPC Session #3
4PM EST Tales from the Road: AI Innovators on their Fundraising Journey Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey Tales from the Road: Age-Tech Innovators on their Fundraising Journey
5PM EST IPC Session #4 IPC Session #7 IPC Session #11

resi-march-2022